IT1248012B - Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione. - Google Patents

Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.

Info

Publication number
IT1248012B
IT1248012B ITMI911578A ITMI911578A IT1248012B IT 1248012 B IT1248012 B IT 1248012B IT MI911578 A ITMI911578 A IT MI911578A IT MI911578 A ITMI911578 A IT MI911578A IT 1248012 B IT1248012 B IT 1248012B
Authority
IT
Italy
Prior art keywords
therapy
phosphatidylinititol
depression disorders
disorders
depression
Prior art date
Application number
ITMI911578A
Other languages
English (en)
Inventor
Pier Giuseppe Pagella
Enrico Ferrari
Stefano Maiorana
Mario Brufani
Original Assignee
Mediolanum Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Spa filed Critical Mediolanum Farmaceutici Spa
Priority to ITMI911578A priority Critical patent/IT1248012B/it
Publication of ITMI911578A0 publication Critical patent/ITMI911578A0/it
Priority to US07/821,088 priority patent/US5214180A/en
Priority to CA002059701A priority patent/CA2059701A1/en
Priority to EP19920100885 priority patent/EP0516914A3/en
Priority to JP4083127A priority patent/JPH0597875A/ja
Publication of ITMI911578A1 publication Critical patent/ITMI911578A1/it
Application granted granted Critical
Publication of IT1248012B publication Critical patent/IT1248012B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invenzione si riferisce all'impiego del fosfatidilinositolo per la preparazione di composizioni farmaceutiche atte alla terapia dei disturbi della depressione.
ITMI911578A 1991-06-07 1991-06-07 Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione. IT1248012B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI911578A IT1248012B (it) 1991-06-07 1991-06-07 Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
US07/821,088 US5214180A (en) 1991-06-07 1992-01-16 Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
CA002059701A CA2059701A1 (en) 1991-06-07 1992-01-20 Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
EP19920100885 EP0516914A3 (en) 1991-06-07 1992-01-20 Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
JP4083127A JPH0597875A (ja) 1991-06-07 1992-03-05 中枢神経系障害の治療に有用な天然給源からの高純度ホスフアチジルイノシトール及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911578A IT1248012B (it) 1991-06-07 1991-06-07 Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.

Publications (3)

Publication Number Publication Date
ITMI911578A0 ITMI911578A0 (it) 1991-06-07
ITMI911578A1 ITMI911578A1 (it) 1992-12-07
IT1248012B true IT1248012B (it) 1995-01-05

Family

ID=11360073

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911578A IT1248012B (it) 1991-06-07 1991-06-07 Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.

Country Status (5)

Country Link
US (1) US5214180A (it)
EP (1) EP0516914A3 (it)
JP (1) JPH0597875A (it)
CA (1) CA2059701A1 (it)
IT (1) IT1248012B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759113A (en) * 1996-06-21 1998-06-02 Minnesota Mining And Manufacturing Company Vibration damped golf clubs and ball bats
US6733797B1 (en) 2000-11-15 2004-05-11 William K. Summers Neuroceutical for improving memory and cognitive abilities
AU2003248927A1 (en) * 2002-07-10 2004-01-23 Massachusetts Institute Of Technology Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
WO2007073559A2 (en) * 2005-12-21 2007-06-28 Nutrimed Biotech Inositolphospholipids and analogues: phosphalidylinositol products and processes
US20100061969A1 (en) * 2006-11-22 2010-03-11 Asahi Kasei Pharma Corporation Dietary supplement, anti-fatigue agent or physical endurance enhancer, functional food, or cosmetic
CN102964380A (zh) * 2012-01-10 2013-03-13 广东省微生物研究所 一种磷脂酰肌醇的化学制备方法
WO2014160285A1 (en) 2013-03-14 2014-10-02 Okay Devin J Compositions for treatment of xerostomia and for tooth treatment
US20220339173A1 (en) * 2019-08-28 2022-10-27 Unitec Foods Co., Ltd. Oral composition for improving memory-learning ability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2287901A1 (fr) * 1974-10-14 1976-05-14 Pasteur Institut Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle
US4482761A (en) * 1982-09-13 1984-11-13 Union Carbide Corporation Bulk separation of inositol and sorbitol by selective adsorption on zeolitic molecular sieves
IT1212900B (it) * 1983-11-17 1989-11-30 Valle Francesco Della Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
US4988682A (en) * 1989-02-03 1991-01-29 University Of Pittsburgh Myo-inositol analogs and method for their use

Also Published As

Publication number Publication date
EP0516914A3 (en) 1993-02-24
US5214180A (en) 1993-05-25
CA2059701A1 (en) 1992-12-08
JPH0597875A (ja) 1993-04-20
EP0516914A2 (en) 1992-12-09
ITMI911578A0 (it) 1991-06-07
ITMI911578A1 (it) 1992-12-07

Similar Documents

Publication Publication Date Title
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
FR2615095B1 (fr) Instrumentation d'osteosynthese pour la correction de scolioses lombaires par voie posterieure
AU1959092A (en) Use of hpv-16 e6 and e7-gene derived peptides for the diagnostic purpose
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
MX9701538A (es) Sales de un derivado del indol contra la migraña.
CA2031714A1 (en) R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
MY111201A (en) New imidazopyridines
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
AU623805B2 (en) New use of anti-progestomimetic compounds
RU94039284A (ru) Производные пиперазина, способ их получения, фармкомпозиция и ее использование
IT1247509B (it) Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
IT1231509B (it) Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
DK317285D0 (da) Farmakologisk virksomme (pyrrol-1-yl)-phenyl-dihydropyridazinoner ogfremgangsmaade til fremstilling heraf
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
ITMI911578A0 (it) Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
ES2096203T3 (es) Nuevos derivados de fisostigmina, su uso y formulaciones farmaceuticas que los contienen.
IT8709430A0 (it) Utilizzazione di forme farmaceutiche per uso topico contenenti miocamicina per la terapia delle infezioni da germi sensibili alla miocamicina stessa
AU1564388A (en) Novel substituted silyl alkylene amines
MX9803791A (es) Intermediarios novedosos y su uso para preparar bisindolilmaleimidas n,n'-puenteadas.
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
EP0322352A3 (en) Use of anti-progestins for preparation of medicaments

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960628